Correlation Between Accenture Plc and Ono Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Accenture Plc and Ono Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Accenture Plc and Ono Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Accenture plc and Ono Pharmaceutical Co, you can compare the effects of market volatilities on Accenture Plc and Ono Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Accenture Plc with a short position of Ono Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Accenture Plc and Ono Pharmaceutical.

Diversification Opportunities for Accenture Plc and Ono Pharmaceutical

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Accenture and Ono is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Accenture plc and Ono Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ono Pharmaceutical and Accenture Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Accenture plc are associated (or correlated) with Ono Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ono Pharmaceutical has no effect on the direction of Accenture Plc i.e., Accenture Plc and Ono Pharmaceutical go up and down completely randomly.

Pair Corralation between Accenture Plc and Ono Pharmaceutical

Considering the 90-day investment horizon Accenture plc is expected to generate 0.92 times more return on investment than Ono Pharmaceutical. However, Accenture plc is 1.09 times less risky than Ono Pharmaceutical. It trades about 0.12 of its potential returns per unit of risk. Ono Pharmaceutical Co is currently generating about -0.1 per unit of risk. If you would invest  29,130  in Accenture plc on August 27, 2024 and sell it today you would earn a total of  6,999  from holding Accenture plc or generate 24.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Accenture plc  vs.  Ono Pharmaceutical Co

 Performance 
       Timeline  
Accenture plc 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Accenture plc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy fundamental indicators, Accenture Plc is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Ono Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ono Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Accenture Plc and Ono Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Accenture Plc and Ono Pharmaceutical

The main advantage of trading using opposite Accenture Plc and Ono Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Accenture Plc position performs unexpectedly, Ono Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ono Pharmaceutical will offset losses from the drop in Ono Pharmaceutical's long position.
The idea behind Accenture plc and Ono Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences